Breast cancer is the most common cancer and the second cause of cancer‐related death in
women worldwide. Chemotherapy of disease is impeded by subsequent relapse and …

Background: This study aimed to develop a novel drug formulation using
polybutylcyanoacrylate (PBCA) nanoparticles to deliver cisplatin, a commonly used …

Poly (alkyl cyanoacrylates) with a higher alkyl chain length is relatively less toxic than those
with a lower alkyl chain length. Several interesting studies were reported on the usefulness …

Nano-drug delivery holds great potential to enhance the efficacy of carboplatin. This study
focused on cytotoxicity, in vitro drug release and characterization of poly (butyl …

The use of doxorubicin (DOX), one of the most effective antitumor molecules in the treatment
of metastatic breast cancer, is limited by its low tumor selectivity and its severe side effects …

We have investigated the biodistribution and tumor macrophage infiltration after intravenous
injection of the poly (alkyl cyanoacrylate) nanoparticles (NPs): PEBCA (poly (2-ethyl-butyl …

Developing novel nanocarriers for anticancer drug delivery has become a 'promising niche'.
The toxicity of the carrier and its efficacy in treatment modalities have become cardinal …

This study aims to improve the cytotoxicity and potency of cisplatin-loaded
polybutylcyanoacrylate (PBCA) nanoparticles (NPs) for the treatment of lung cancer through …

Glioblastoma is known as one of the most aggressive human cancers. To gain access of the
brain, therapeutic agents must overcome blood–brain barrier (BBB). In this study, Cisplatin …

This paper surveys the current status of anticancer drug delivery by means of
polyalkylcyanoacrylate nanoparticles. In spite of the development of numerous …